These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 26804643)

  • 61. Design and Synthesis of Substituted Pyridazinone-1-Acetylhydrazones as Novel Phosphodiesterase 4 Inhibitors.
    Abdel-Rahman HM; Abdel-Aziz M; Tinsley HN; Gary BD; Canzoneri JC; Piazza GA
    Arch Pharm (Weinheim); 2016 Feb; 349(2):104-11. PubMed ID: 26686665
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Investigation of non-hydroxamate scaffolds against HDAC6 inhibition: A pharmacophore modeling, molecular docking, and molecular dynamics simulation approach.
    Zeb A; Park C; Son M; Rampogu S; Alam SI; Park SJ; Lee KW
    J Bioinform Comput Biol; 2018 Jun; 16(3):1840015. PubMed ID: 29945500
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Structural insight into selective phosphodiesterase 4B inhibitors: pharmacophore-based virtual screening, docking, and molecular dynamics simulations.
    Sharma V; Wakode S
    J Biomol Struct Dyn; 2017 May; 35(6):1339-1349. PubMed ID: 27136969
    [No Abstract]   [Full Text] [Related]  

  • 64. Structure-guided Design and Optimization of small Molecules as Pancreatic Lipase Inhibitors using Pharmacophore, 3D-QSAR, Molecular Docking, and Molecular Dynamics Simulation Studies.
    Modanwal S; Mulpuru V; Mishra N
    Curr Comput Aided Drug Des; 2023; 19(4):258-277. PubMed ID: 36597611
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Identification of potential AMPK activator by pharmacophore modeling, molecular docking and QSAR study.
    Li Y; Peng J; Li P; Du H; Li Y; Liu X; Zhang L; Wang LL; Zuo Z
    Comput Biol Chem; 2019 Apr; 79():165-176. PubMed ID: 30836318
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A Combined Approach of Pharmacophore Modeling, QSAR Study, Molecular Docking and In silico ADME/Tox Prediction of 4-Arylthio & 4-Aryloxy-3- Iodopyridine-2(1H)-one Analogs to Identify Potential Reverse Transcriptase Inhibitor: Anti-HIV Agents.
    Panigrahi D; Mishra A; Sahu SK; Azam MA; Vyshaag CM
    Med Chem; 2022; 18(1):51-87. PubMed ID: 33319692
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacophore model, docking, QSAR, and molecular dynamics simulation studies of substituted cyclic imides and herbal medicines as COX-2 inhibitors.
    Moussa N; Hassan A; Gharaghani S
    Heliyon; 2021 Apr; 7(4):e06605. PubMed ID: 33889764
    [TBL] [Abstract][Full Text] [Related]  

  • 68. 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, MD simulations, in vitro and in vivo studies to identify potential anti-hyperplasia drugs.
    Khan MZI; Khan D; Akbar MY; Wang H; Haq IU; Chen JZ
    Biotechnol J; 2024 Feb; 19(2):e2300437. PubMed ID: 38403464
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of Hydroxamic Acid Based Selective HDAC1 Inhibitors: Computer Aided Drug Design Studies.
    Patel P; Patel VK; Singh A; Jawaid T; Kamal M; Rajak H
    Curr Comput Aided Drug Des; 2019; 15(2):145-166. PubMed ID: 29732991
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pharmacophore generation and atom-based 3D-QSAR of novel 2-(4-methylsulfonylphenyl)pyrimidines as COX-2 inhibitors.
    Shah UA; Deokar HS; Kadam SS; Kulkarni VM
    Mol Divers; 2010 Aug; 14(3):559-68. PubMed ID: 19669924
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Atom-based 3D-QSAR, induced fit docking, and molecular dynamics simulations study of thieno[2,3-b]pyridines negative allosteric modulators of mGluR5.
    Vijaya Prabhu S; Singh SK
    J Recept Signal Transduct Res; 2018 Jun; 38(3):225-239. PubMed ID: 29806525
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Molecular modeling studies of pyridopurinone derivatives--potential phosphodiesterase 5 inhibitors.
    Srivani P; Srinivas E; Raghu R; Sastry GN
    J Mol Graph Model; 2007 Jul; 26(1):378-90. PubMed ID: 17307372
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pharmacophore modeling, atom based 3D-QSAR, molecular docking and molecular dynamics studies on Escherichia coli ParE inhibitors.
    Azam MA; Thathan J; Jupudi S
    Comput Biol Chem; 2020 Feb; 84():107197. PubMed ID: 31901788
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ligand-based pharmacophore modelling and virtual screening for the identification of amyloid-beta diagnostic molecules.
    Marondedze EF; Govender KK; Govender PP
    J Mol Graph Model; 2020 Dec; 101():107711. PubMed ID: 32898834
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Molecular docking, 3D QSAR and dynamics simulation studies of imidazo-pyrrolopyridines as janus kinase 1 (JAK 1) inhibitors.
    Itteboina R; Ballu S; Sivan SK; Manga V
    Comput Biol Chem; 2016 Oct; 64():33-46. PubMed ID: 27244086
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Combined 3D-QSAR, molecular docking, and molecular dynamics study on piperazinyl-glutamate-pyridines/pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregation.
    Hao M; Li Y; Wang Y; Yan Y; Zhang S; Li G; Yang L
    J Chem Inf Model; 2011 Oct; 51(10):2560-72. PubMed ID: 21923153
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacophore based 3D-QSAR modeling and free energy analysis of VEGFR-2 inhibitors.
    Rajagopalan M; Balasubramanian S; Ramaswamy A; Mathur PP
    J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1236-46. PubMed ID: 23061928
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Docking-assisted 3D-QSAR studies on xanthones as α-glucosidase inhibitors.
    Zheng X; Zhou S; Zhang C; Wu D; Luo HB; Wu Y
    J Mol Model; 2017 Aug; 23(9):272. PubMed ID: 28861624
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacophore, 3D-QSAR Models and Dynamic Simulation of 1,4-Benzothiazines for Colorectal Cancer Treatment.
    Rai A; Raj V; Aboumanei MH; Singh AK; Keshari AK; Verma SP; Saha S
    Comb Chem High Throughput Screen; 2017; 20(8):658-674. PubMed ID: 28486913
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Combined 2D and 3D-QSAR, molecular modelling and docking studies of pyrazolodiazepinones as novel phosphodiesterase 2 inhibitors.
    Bhansali SG; Kulkarni VM
    SAR QSAR Environ Res; 2014; 25(11):905-37. PubMed ID: 25401514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.